On Tuesday, Shares of Goldcorp Inc. (USA) (NYSE:GG), gained 1.84% to $13.31.
Goldcorp stated record second quarter gold production of 908,000 ounces, contrast to gold production of 648,700 ounces for the second quarter of 2014. Adjusted quarterly revenues were $1.3 billion, generating adjusted net earnings of $65 million, or $0.08 per share, contrast to adjusted net earnings of $164 million, or $0.20 per share, for the second quarter of 2014. Adjusted operating cash flow was $358 million, contrast to $376 million for the second quarter of 2014. Stated net earnings attributable to shareholders of Goldcorp for the quarter were $392 million, or $0.47 per share, contrast to net earnings of $181 million, or $0.22 per share, for the second quarter of 2014.
Goldcorp Inc. engages in the acquisition, exploration, development, and operation of precious metal properties in Canada, the United States, Mexico, and Central and South America. The company primarily explores for gold, silver, copper, lead, and zinc deposits.
Shares of Halyard Health Inc (NYSE:HYH), declined -11.75% to $35.09, during its last trading session.
Halyard Health, stated second quarter 2015 results, updated its net sales, and adjusted diluted earnings per share outlook for full-year 2015.
Executive Summary
- Second quarter 2015 net sales were $389 million, down 6 percent from the same period last year. On a constant currency basis, net sales reduced 3 percent in the period.
- Net income for the second quarter 2015 was $8 million contrast to net loss of $(5) million in the second quarter of 2014. Second quarter adjusted net income was $24 million contrast to $49 million in the preceding year.
- Second quarter diluted earnings per share were $0.17, contrast to $(0.10) in the second quarter of 2014. Adjusted diluted earnings per share in the quarter were $0.52, contrast to $1.06 in the preceding year.
- Year-to-date 2015 net sales were $784 million, down 5 percent. Net sales on a constant currency basis declined 2 percent.
- Net income for the first six months of 2015 was $30 million contrast to $37 million from the same period a year ago.
- Through six months, diluted earnings per share were $0.63, contrast to $0.79 a year ago. Adjusted diluted earnings per share for the first half of 2015 were $1.03, contrast to $2.15 in the preceding year.
- The Company updates full-year 2015 net sales and adjusted diluted earnings per share outlook.
Halyard Health, Inc. provides health and healthcare supplies and solutions worldwide. It operates through two segments, Surgical and Infection Prevention (S&IP), and Medical Devices.
Finally, Olin Corporation (NYSE:OLN), ended its last trade with 0.31% gain, and closed at $22.47.
Olin Corporation declared that its second quarter 2015 income from ongoing operations was $42.3 million or $0.54 per diluted share, which compares to income from ongoing operations of $36.6 million, or $0.46 per diluted share in the second quarter of 2014. Sales in the second quarter of 2015 were $535.4 million contrast to $570.4 million in the second quarter of 2014.
Second quarter 2015 results comprised of a pretax gain of $52.2 million related to property damage and business interruption insurance recoveries resulting from the June 2014 incident at one of the two chlor alkali production units at our Becancour, Canada facility. Second quarter 2015 results also comprised of pretax acquisition-related financing and other costs of $22.1 million, raised legacy environmental costs of $3.9 million and pretax restructuring charges of $0.7 million.
Olin Corporation manufactures and sells chlor alkali products in the United States and internationally. The company operates through three segments: Chlor Alkali Products, Chemical Distribution, and Winchester.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
